Novavax, Inc.

NASDAQ:NVAX   11:34:48 AM EDT
78.63
+5.71 (+7.83%)
Business Deals

Mabion Gets Additional Order For Production Of Cell Banks Under Deal With Novavax

Published: 01/14/2022 07:35 GMT
Novavax, Inc. (NVAX) - Gets Additional Order for Production of Cell Banks Under Deal With Novavax.
Project to Be Carried Out in Q1.
Value of Statement of Works 3 is Not Significant Versus Original Production Deal But Expands Cooperation With Novavax Into New Field.
Under Statement of Work 3 Company Will Produce Bank Cells Based on Gmp Which Will Be Used As Key Biological Material in Producing Novavax Vaccine Antigens .